Related Experiment Video
Updated: Aug 19, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic
1Institutes of Biology and Medical Sciences, Soochow University, China.
Abstract:
Synthetic lethality (SL) represents the co-occurrence of two or more non-lethal disordered genes that could lead to cell death. SL-based anticancer therapeutics could specifically kill the cancer cells carrying the targeted mutated gene while leaving normal cells alive. Recent large-scale computational and experimental screenings provide rich resources of SL information while lacking systematic research on molecular features of SL genes. Combined with comprehensive multi-omics data analysis and experimental validation of one SL gene pair, Guo et al. portrayed a systematic layout of cancer-specific SL interactions that could improve understanding of carcinogenesis and potentially assist the subsequent screening of anticancer therapeutic targets.
Insights
Synthetic lethality (SL) uses gene pairs to kill cancer cells while sparing normal cells. This study systematically maps cancer-specific SL interactions, aiding the discovery of new cancer drug targets.
Area of Science:
- Oncology
- Genetics
- Computational Biology
Background:
- Synthetic lethality (SL) involves gene pairs where mutations in both are lethal, but in only one are non-lethal.
- SL-based therapeutics offer targeted cancer cell killing, sparing healthy cells.
- Existing SL resources lack systematic analysis of the molecular features of SL genes.
Purpose of the Study:
- To systematically analyze cancer-specific synthetic lethality interactions.
- To explore the molecular characteristics of genes involved in synthetic lethality.
- To identify potential new targets for anticancer therapeutics.
Main Methods:
- Comprehensive multi-omics data analysis.
- Computational screening of large-scale genetic interaction datasets.
- Experimental validation of a specific synthetic lethality gene pair.
Main Results:
- A systematic map of cancer-specific SL interactions was generated.
- Insights into the molecular features distinguishing SL genes were gained.
- One SL gene pair was experimentally validated, demonstrating feasibility.
Conclusions:
- Systematic analysis of SL interactions enhances understanding of carcinogenesis.
- The generated map can guide the screening of novel anticancer therapeutic targets.
- This approach holds promise for developing more precise cancer treatments.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

